Clinical Trials List
Protocol Number101-1240A
2015-11-24 - 2019-12-31
Phase I
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 黃致任 Division of Cardiovascular Diseases
- 馬銘君 Division of Cardiovascular Diseases
- 李芳艷 Division of Cardiovascular Diseases
- 陳淑芳 Division of Cardiovascular Diseases
- 陳永隆 Division of Cardiovascular Diseases
- 張文能 Division of Cardiovascular Diseases
- 黃淑華 Division of Cardiovascular Diseases
- 盧成憲 Division of Cardiovascular Diseases
- 林偉哲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
0 participants
